Evaluating Treatment Preferences for HIV Therapy
Author Information
Author(s): Garris Cindy, Kolobova Irina, Chounta Vasiliki, Díaz De Santiago Alberto, Dretler Robin, Singh Tulika, Sinclair Gary
Primary Institution: ViiV Healthcare
Hypothesis
The study aims to assess the relevance and interpretability of survey questions regarding treatment preferences for daily oral versus long-acting injectable antiretroviral therapy among people living with HIV.
Conclusion
The study confirmed that the treatment preference question and three emotional well-being questions are relevant and well understood by adults living with HIV.
Supporting Evidence
- Participants expressed a desire for less frequent dosing and reduced emotional burden associated with daily oral ART.
- Most participants found their current treatment regimen easy to manage despite the daily reminder of their HIV status.
- Participants highlighted fear of disclosure and adherence anxiety as significant factors influencing their treatment preferences.
Takeaway
This study asked people living with HIV how they feel about taking their medicine every day versus getting injections every couple of months, and found that many prefer the injections because they are easier and less stressful.
Methodology
The study used a cross-sectional qualitative design involving concept confirmation and cognitive debriefing interviews with participants currently receiving HIV treatment.
Potential Biases
Participants were primarily from a well-educated US population, which may limit the generalizability of the findings.
Limitations
The study did not explore other clinical characteristics or psychosocial constructs that might influence participant feedback or HIV treatment experience.
Participant Demographics
{"mean_age":48.5,"age_range":"29-68","gender_distribution":{"male":60,"female":40},"racial_distribution":{"Black":40,"White":40,"other":20}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website